Supplementary Data — HH-120 for COVID-19: real-time meta-analysis of 2 studies

@CovidAnalysis, October 2026, Version 2V2 (V1 2023)

.fp--anim .fp__study,.fp--anim .fp__sum,.fp--anim .fp__het,.fp--anim .fp__dia,.fp--anim .fp__verdict,.fp--anim .fp__pooled{opacity:1}.fp--anim .fp__ci{transform:none}.fp--anim .fp__pt{transform:translate(-50%,-50%)}.fp--anim .fp__plot::before{opacity:var(--shade-opacity)}.fp--anim-settle .fp__pt{left:calc(min(var(--pt),var(--max))/var(--max)*100%)}.fp--anim-settle .fp__ci,.fp--anim-settle .fp__dia{left:calc(var(--lo)/var(--max)*100%);width:calc((var(--hi) - var(--lo))/var(--max)*100%)}

c19early.org

October 2026

HH-120 COVID-19 outcomes

StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk

Song (PSM)20%0.80 · 0.70–0.91viral time65 (n)103 (n) Song76%0.24 · 0.07–0.81symp. case120 (n)57 (n) Song76%0.24 · 0.02–2.61symp. case1/1202/57Part 1 Song76%0.24 · 0.06–0.97symp. case3/406/22Part 2 Song58%0.42 · 0.19–0.91cases124 (n)62 (n) Song66%0.34 · 0.11–1.08cases5/1247/62Part 1 Song50%0.50 · 0.17–1.42cases7/417/23Part 2

00.511.52+

Rotate screen for more detailsIncrease width for more details

← HH-120
reduces riskHH-120
increases risk →

Fig. S1. All outcomes.